北京天星医疗股份有限公司（股票代码：01609）于2026年10月7日发布公告，披露当日公司在香港联交所场内回购2,950股H股，占回购前公司已发行股本(不包括库存股)约0.01%，每股回购价格介乎每股74.80港元至76.35港元，合计涉资约22.40万港元。
回购完成后，公司已发行股本(不包括库存股)为54,784,144股，库存股份总数为47,200股。公司回购授权决议通过日期为2026年6月26日，获授权可回购股份总数为5,483,134股。公告显示，公司已根据上市规则及相关法规合规进行本次回购。
公告由联席公司秘书梁晓丹签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.